; As We See It
Learning Center
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

As We See It


The incoming FDA commissioner faces something akin to the theme of the old Mission Impossible television series as the agency admits to yet another management gaffe in its bizarre "disinvitation," at Eli Lilly's request, of a dissident voice on an advisory committee days before it was to vote on the company's new drug, prasugrel. Absent that voice, belonging to Sanjay Kaul, a Cedars-Sinai Heart Institute cardiologist, the panel voted 9-0 in favor of prasugrel's approval.

More Info
  • pg 1
									As We See It
James G Dickinson
Medical Marketing and Media; Apr 2009; 44, 4; Docstoc
pg. 32

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

To top